Studies regarding the protective effects exhibited by antidepressants on cell models

Area of Science:

• Pharmacology
• Cell Biology
• Neuroscience

Background:

• Antidepressants such as fluoxetine, sertraline, and venlafaxine are widely prescribed for major depressive disorder.
• Their known mechanisms primarily involve neurotransmitter modulation.
• Potential non-pharmacological cellular effects remain less understood.

Purpose of the Study:

• To investigate the in vitro short-term physiological effects of fluoxetine, sertraline, and venlafaxine.
• To assess impacts on U937 monocyte cell membranes and erythrocyte oxidative stress markers.
• To correlate effects with antidepressant treatment in patients with depression.

Main Methods:

• U937 monocyte cell suspensions were exposed to varying concentrations of the three antidepressants.
• Erythrocytes were isolated from patients undergoing treatment with these antidepressants.
• Assessed parameters included cell membrane depolarization, lipid peroxidation susceptibility, and glucose-6-phosphate dehydrogenase activity.

Main Results:

• Fluoxetine, sertraline, and venlafaxine induced concentration-dependent, non-monotonic cell membrane depolarization in U937 monocytes, with maximal effect at 15 minutes.
• Fluoxetine exhibited the strongest depolarizing effect.
• Antidepressant treatment in patients decreased erythrocyte susceptibility to lipid peroxidation and increased glucose-6-phosphate dehydrogenase activity, indicating enhanced antioxidant defense.
• These effects were more pronounced in severe depression (higher MADRS scores).

Conclusions:

• Therapeutic concentrations of fluoxetine, sertraline, and venlafaxine exert direct cellular effects beyond neurotransmitter modulation.
• These antidepressants appear to offer a protective effect against oxidative stress in erythrocytes.
• The findings suggest antidepressants may influence immune cells, warranting further investigation into their broader physiological roles.